Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Circulation. Arrhythmia and Electrophysiology
|
December 13, 2024
Performance of ARVC Risk Calculators in (Likely) Pathogenic Plakophilin-2 Variant Carriers Without Definite ARVC Diagnosis
Steven A Muller, Babken Asatryan, Brittney Murray, et al.
Circulation. Arrhythmia and Electrophysiology
|
July 2, 2026
Yield of Family Screening in Arrhythmogenic Right Ventricular Cardiomyopathy Without a Validated Genetic Cause
Steven A Muller, Brittney Murray, Crystal Tichnell, et al.
Circulation. Arrhythmia and Electrophysiology
|
October 31, 2022
Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
Richard T Carrick, Anneline S J M Te Riele, Alessio Gasperetti, et al.
Circulation
|
June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Steven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
JACC. Advances
|
June 17, 2026
Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International Cohort
Ethan J Rowin, Deacon Z J Lee, Mark V Sherrid, et al.
JACC. Clinical Electrophysiology
|
April 17, 2025
Long-Term Follow-Up Data on Flecainide Use as an Antiarrhythmic in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multicenter Study
Sean Gaine, Thomas Rolland, Babken Asatryan, et al.
Circulation
|
October 7, 2022
Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
Alessio Gasperetti, Richard T Carrick, Sarah Costa, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study
Olives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Journal of Cardiac Failure
|
March 3, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study
Olives Nguyen, Jack Wiedrick, Daniele Massera, et al.
European Heart Journal
|
January 9, 2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Richard T Carrick, Corrado De Marco, Alessio Gasperetti, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Circulation. Arrhythmia and Electrophysiology
|
December 13, 2024
Performance of ARVC Risk Calculators in (Likely) Pathogenic Plakophilin-2 Variant Carriers Without Definite ARVC Diagnosis
Steven A Muller, Babken Asatryan, Brittney Murray, et al.
Circulation. Arrhythmia and Electrophysiology
|
July 2, 2026
Yield of Family Screening in Arrhythmogenic Right Ventricular Cardiomyopathy Without a Validated Genetic Cause
Steven A Muller, Brittney Murray, Crystal Tichnell, et al.
Circulation. Arrhythmia and Electrophysiology
|
October 31, 2022
Longitudinal Prediction of Ventricular Arrhythmic Risk in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy
Richard T Carrick, Anneline S J M Te Riele, Alessio Gasperetti, et al.
Circulation
|
June 17, 2025
Family Screening in Relatives at Risk for Plakophilin-2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy
Steven A Muller, Babken Asatryan, Alessio Gasperetti, et al.
JACC. Advances
|
June 17, 2026
Clinical Spectrum and Outcomes in Hypertrophic Cardiomyopathy With Apical Aneurysms: A Large Multicenter International Cohort
Ethan J Rowin, Deacon Z J Lee, Mark V Sherrid, et al.
JACC. Clinical Electrophysiology
|
April 17, 2025
Long-Term Follow-Up Data on Flecainide Use as an Antiarrhythmic in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multicenter Study
Sean Gaine, Thomas Rolland, Babken Asatryan, et al.
Circulation
|
October 7, 2022
Programmed Ventricular Stimulation as an Additional Primary Prevention Risk Stratification Tool in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Study
Alessio Gasperetti, Richard T Carrick, Sarah Costa, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 26, 2025
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study
Olives Nguyen, Jack Wiedrick, Daniele Massera, et al.
Journal of Cardiac Failure
|
March 3, 2026
Incidence and Outcomes of Atrial Fibrillation and Systolic Dysfunction in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy: A Multicenter Study
Olives Nguyen, Jack Wiedrick, Daniele Massera, et al.
European Heart Journal
|
January 9, 2024
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
Richard T Carrick, Corrado De Marco, Alessio Gasperetti, et al.
Page
of 6